Halofuginone dually regulates autophagic flux through nutrient-sensing pathways in colorectal cancer

Guo-Qing Chen1,2, Rui-Hong Gong1, Da-Jian Yang2

  • 1Laboratory of Brain and Gut Research, Center for Clinical Research on Chinese Medicine, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China.

Insights

Halofuginone (HF) shows dual regulation of autophagy in colorectal cancer (CRC) by modulating ULK1 activity based on nutrient availability, impacting tumor growth.

Area of Science:

  • Cellular Biology
  • Cancer Research
  • Metabolism

Background:

  • Autophagy plays a crucial role in cellular metabolism and tumorigenesis.
  • Halofuginone (HF) previously demonstrated anticancer effects in colorectal cancer (CRC) by inhibiting the Akt/mTORC1 pathway.
  • The precise mechanisms by which HF influences autophagy and metabolism in cancer remain unclear.

Purpose of the Study:

  • To elucidate how halofuginone (HF) regulates autophagy and metabolism in colorectal cancer (CRC) under varying nutritional conditions.
  • To investigate the role of ULK1, Akt/mTORC1, and LKB1/AMPK signaling pathways in HF-mediated autophagy modulation.
  • To determine the impact of HF on glucose metabolism and tumor growth in vivo.

Main Methods:

  • Investigated HF effects on ULK1 phosphorylation at specific sites (Ser757, Ser317, Ser777) in relation to Akt/mTORC1 and LKB1/AMPK signaling.
  • Assessed Atg7-dependent autophagosome formation under nutrient-rich and nutrient-poor conditions.
  • Analyzed HF's impact on glycolysis and gluconeogenesis.
  • Evaluated HF's anti-tumor efficacy in xenograft mouse models with different dietary conditions.

Main Results:

  • HF activates ULK1 via Akt/mTORC1, inducing autophagy under nutrient-rich conditions.
  • HF inactivates ULK1 via LKB1/AMPK, inhibiting autophagy under nutrient-poor conditions.
  • HF modulates glucose metabolism (inhibiting glycolysis or gluconeogenesis) in an Atg7-dependent manner.
  • HF treatment suppressed tumor growth in vivo, irrespective of diet, due to dual autophagy regulation.

Conclusions:

  • Halofuginone exhibits a context-dependent dual role in autophagy modulation in colorectal cancer.
  • HF's regulation of autophagy is intricately linked to nutritional status and impacts glucose metabolism.
  • These findings highlight HF as a potential therapeutic agent for CRC, leveraging its ability to dual-regulate autophagy for anti-tumor effects.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K